Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

1.

Complete remission of refractory immune thrombocytopenia (ITP) with a short course of Romiplostim.

Thachil J, Salter I, George JN.

Eur J Haematol. 2013 Oct;91(4):376-7. doi: 10.1111/ejh.12165. Epub 2013 Aug 17. No abstract available.

PMID:
23822831
[PubMed - indexed for MEDLINE]
2.

Use of the novel thrombopoietin receptor-agonist romiplostim, in combination with steroids and immunoglobulins for the increase of platelets prior to splenectomy, in refractory immune thrombocytopenia: a case report.

Sivera P, Ruella M, Gueli A, Hu H, Wade M, Tarella C.

Blood Coagul Fibrinolysis. 2012 Jun;23(4):331-4. doi: 10.1097/MBC.0b013e3283513a97.

PMID:
22343685
[PubMed - indexed for MEDLINE]
3.

Romiplostim for the treatment of primary immune thrombocytopenia.

Janssens A.

Expert Rev Hematol. 2012 Apr;5(2):133-44. doi: 10.1586/ehm.12.6.

PMID:
22475281
[PubMed - indexed for MEDLINE]
4.

Romiplostim in chronic immune thrombocytopenic purpura.

Cersosimo RJ.

Clin Ther. 2009 Sep;31(9):1887-907. doi: 10.1016/j.clinthera.2009.09.013. Review.

PMID:
19843480
[PubMed - indexed for MEDLINE]
5.

Immune thrombocytopenia and anticoagulation: the role of romiplostim in the early treatment.

Cantoni N, Heizmann M, Bargetzi M.

Br J Haematol. 2012 Jun;157(5):639-41. doi: 10.1111/j.1365-2141.2012.09051.x. Epub 2012 Feb 14. No abstract available.

PMID:
22329466
[PubMed - indexed for MEDLINE]
6.

Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use program.

Khellaf M, Michel M, Quittet P, Viallard JF, Alexis M, Roudot-Thoraval F, Cheze S, Durand JM, Lefrère F, Galicier L, Lambotte O, Panelatti G, Slama B, Damaj G, Sebahoun G, Gyan E, Delbrel X, Dhedin N, Royer B, Schleinitz N, Rossi JF, Mahévas M, Languille L, Bierling P, Godeau B.

Blood. 2011 Oct 20;118(16):4338-45. doi: 10.1182/blood-2011-03-340166. Epub 2011 Aug 10.

PMID:
21832276
[PubMed - indexed for MEDLINE]
Free Article
7.

Evaluation of bleeding and thrombotic events during long-term use of romiplostim in patients with chronic immune thrombocytopenia (ITP).

Gernsheimer TB, George JN, Aledort LM, Tarantino MD, Sunkara U, Matthew Guo D, Nichol JL.

J Thromb Haemost. 2010 Jun;8(6):1372-82. doi: 10.1111/j.1538-7836.2010.03830.x. Epub 2010 Mar 3.

PMID:
20230419
[PubMed - indexed for MEDLINE]
8.

Thrombopoietin receptor agonists in refractory immune thrombocytopenia: differential responses to eltrombopag and romiplostim: a case report and possible explanations.

Aoki T, Harada Y, Matsubara E, Suzuki T, Oyama T, Kasai M, Uchida T, Ogura M.

J Clin Pharm Ther. 2012 Dec;37(6):729-32. doi: 10.1111/j.1365-2710.2012.01353.x. Epub 2012 May 14.

PMID:
22583038
[PubMed - indexed for MEDLINE]
9.

Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonists.

Ghadaki B, Nazi I, Kelton JG, Arnold DM.

Transfusion. 2013 Nov;53(11):2807-12. doi: 10.1111/trf.12139. Epub 2013 Mar 3.

PMID:
23451917
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Romiplostim therapy in children with unresponsive chronic immune thrombocytopenia.

Mokhtar GM, Tantawy AA, El Sherif NH.

Platelets. 2012;23(4):264-73. doi: 10.3109/09537104.2011.619601. Epub 2012 Apr 3.

PMID:
22471399
[PubMed - indexed for MEDLINE]
11.

Thrombopoietin receptor agonists can be used temporarily with patients suffering from refractory chronic lymphocytic leukemia-associated immunologic thrombocytopenia.

Sinisalo M, Sankelo M, Itälä-Remes M.

Leuk Lymphoma. 2011 Apr;52(4):724-5. doi: 10.3109/10428194.2010.551794. Epub 2011 Feb 16. No abstract available.

PMID:
21323511
[PubMed - indexed for MEDLINE]
12.

Cost effectiveness of romiplostim for the treatment of chronic immune thrombocytopenia in Ireland.

Lee D, Thornton P, Hirst A, Kutikova L, Deuson R, Brereton N.

Appl Health Econ Health Policy. 2013 Oct;11(5):457-69. doi: 10.1007/s40258-013-0044-y. Erratum in: Appl Health Econ Health Policy. 2013 Dec;11(6):687.

PMID:
23857462
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Use of romiplostim in a hemodialysis patient with primary immune thrombocytopenia.

Al-Jafar H, Giagounidis A, El-Rashaid K, Al-Ali M, Hakim AA.

Ann Pharmacother. 2012 Nov;46(11):e31. doi: 10.1345/aph.1R134. Epub 2012 Oct 31.

PMID:
23115229
[PubMed - indexed for MEDLINE]
14.

Romiplostim for chronic lymphocytic leukemia-associated immune thrombocytopenia.

D'Arena G, Cascavilla N.

Leuk Lymphoma. 2011 Apr;52(4):701-4. doi: 10.3109/10428194.2010.542598. Epub 2010 Dec 20. No abstract available.

PMID:
21171868
[PubMed - indexed for MEDLINE]
15.

Combined romiplostim and intravenous immunoglobulin therapy increased platelet count, facilitating splenectomy in a patient with refractory immune thrombocytopenic purpura unresponsive to monotherapy.

Mitsuhashi K, Ishiyama M, Imai Y, Shiseki M, Mori N, Teramura M, Seshimo A, Motoji T.

Br J Haematol. 2012 Sep;158(6):798-800. doi: 10.1111/j.1365-2141.2012.09220.x. Epub 2012 Jul 3. No abstract available.

PMID:
22758388
[PubMed - indexed for MEDLINE]
16.

The burden of immune thrombocytopenia in adults: evaluation of the thrombopoietin receptor agonist romiplostim.

Deuson R, Danese M, Mathias SD, Schoonen M, Fryzek J.

J Med Econ. 2012;15(5):956-76. doi: 10.3111/13696998.2012.688902. Epub 2012 May 23. Review.

PMID:
22533524
[PubMed - indexed for MEDLINE]
17.

Increasing platelets without transfusion: is it time to introduce novel thrombopoietic agents in neonatal care?

Sallmon H, Gutti RK, Ferrer-Marin F, Liu ZJ, Sola-Visner MC.

J Perinatol. 2010 Dec;30(12):765-9. doi: 10.1038/jp.2010.50. Epub 2010 Apr 22.

PMID:
20410910
[PubMed - indexed for MEDLINE]
18.

Romiplostim: new drug. Thrombocytopenic purpura: for selected patients, with close monitoring.

[No authors listed]

Prescrire Int. 2009 Dec;18(104):246. No abstract available.

PMID:
20020571
[PubMed - indexed for MEDLINE]
19.

Infection-related transient loss of response and other early side effects in chronic ITP during treatment with thrombopoietin mimetics.

Meyer O, Salama A.

Onkologie. 2011;34(1-2):10-3. doi: 10.1159/000323347. Epub 2011 Jan 17.

PMID:
21346379
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk